top of page

FOXO4-DRI

$500.00Price
Quantity
10mg
10mg 10 Bottles
Purity Grade
Quantity

Typical Dosing Protocols (Research/Compounded Use Only) – FOXO4-DRI

  • Common protocol: 3 mg subcutaneously every other day for 6 days (total of 3 doses per cycle). Cycles are typically repeated 1–3 times per year with several months between cycles.

  • Other reported ranges:

    • Standard short cycle: 3 mg every other day × 3 doses (most common)

    • Alternative: 250–500 mcg to 1 mg daily for 10–30 days (some clinic protocols)

    • Lower starting: 100–300 mcg daily with gradual titration

  • Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).

    • 3 mg = 0.6 mL (60 units on U-100 insulin syringe)

  • Administration: Subcutaneous injection (abdomen or thigh), usually in the morning.

Dosing is highly individualized based on goals and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.

  • Key Potential Benefits of FOXO4-DRI

    1. Selective Clearance of Senescent Cells (Senolytic Action)

      • Disrupts the FOXO4-p53 interaction in senescent ("zombie") cells, promoting their natural apoptosis while largely sparing healthy cells.

      • Targets accumulated senescent cells that drive chronic inflammation and tissue dysfunction in aging and stress models.

      • Supports broader cellular cleanup, potentially reducing the senescence-associated secretory phenotype (SASP) that contributes to age-related decline.

    2. Support for Tissue Rejuvenation and Organ Function

      • In preclinical models, associated with improved kidney function by clearing senescent renal cells and reducing glomerulosclerosis.

      • Enhances vascular and endothelial function, helping delay vascular aging and improve aortic resilience.

      • Promotes cartilage and joint tissue health by selectively removing senescent chondrocytes, potentially aiding regenerative capacity.

    3. Enhanced Reproductive Health and Hormonal Balance in Aged Models

      • Improves the testicular microenvironment in naturally aged subjects, increasing testosterone synthesis-related proteins and serum testosterone levels.

      • Supports better spermatogenesis, sperm concentration, motility, and overall sperm quality.

      • Contributes to restored Leydig cell function, addressing aspects of age-related hormonal insufficiency.

    4. Improved Physical Performance and Vitality

      • Linked to increased activity levels, muscle mass preservation, and fur density in aged animal models, suggesting benefits for physical resilience.

      • May enhance mitochondrial function and energy production at the cellular level, supporting metabolic health and stamina.

      • Aids in counteracting chemotherapy- or stress-induced tissue damage, promoting faster recovery of organ and systemic function.

    5. Anti-Aging and Longevity Support

      • Addresses a root mechanism of aging by reducing senescent cell burden, which is associated with better healthspan markers in research models.

      • Contributes to youthful tissue regeneration, reduced inflammation, and overall physiological resilience.

      • Potential aesthetic and functional perks include support for skin, hair, and connective tissue health through improved cellular turnover.

    6. Metabolic and Body Composition Benefits

      • Encourages healthier metabolic signaling and fat management by optimizing cellular environments.

      • Supports nutrient utilization and energy expenditure in rejuvenated tissues, potentially aiding favorable body composition shifts.

      • Enhances overall mitochondrial efficiency and cellular repair processes for sustained daily vitality.

bottom of page